# BIODOL THERAPEUTICS: Pharmaceuticals, Montarnaud, France

> BIODOL THERAPEUTICS: BIODOL THERAPEUTICS is a French biotechnology company founded in 2015, focused on developing non-opioid treatments for chronic and...

Source: https://millionrounds.com/startup/biodol-therapeutics (Millionrounds; every figure on the page links to its filing or article)

France · [Pharmaceuticals startup](https://millionrounds.com/companies)

# BIODOL THERAPEUTICS

BIODOL THERAPEUTICS is a French biotechnology company founded in 2015, focused on developing non-opioid treatments for chronic and neuropathic pain.

Funding reported Last round: Grant

Pharmaceuticals Montarnaud, France

Company summary

- **Founded:** 2015 11 years old
- **Team:** 10 1 to 10 people
- **Funding reported:** 11.5M as listed, currency not stated
- **Last round:** Grant May 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for BIODOL THERAPEUTICS has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About BIODOL THERAPEUTICS

BIODOL THERAPEUTICS is a French biotechnology company founded in 2015, focused on developing non-opioid treatments for chronic and neuropathic pain.

Headquartered in Montarnaud, France, the company aims to create innovative therapies that target the immune-nervous system interaction involved in pain. BIODOL has raised approximately $5.36 million in funding, primarily from V-Bio Ventures, and is led by CEO Fabien Granier, along with Dr. Marie Gourlay-Chu and Dr. Loïc Laplanche. The company's core technology centers on the FLT3 receptor, which plays a crucial role in chronic neuropathic pain. BIODOL develops FLT3 inhibitors and Negative Allosteric Modulators (NAMs) to block the binding of the cytokine FL to the FLT3 receptor. Their product pipeline includes BDT272, currently in Phase 1 clinical trials, and a series of FLT3 selective antagonists. BIODOL serves the healthcare industry, providing solutions for patients suffering from various pain conditions, while also addressing the opioid crisis by developing safer, non-opioid alternatives.

## What company datasets say BIODOL THERAPEUTICS raised

Funding, as reported

Reported in all **11.5M** in the source's currency

Rounds **2**

Last round **Grant**

Last round size **7.7M**

Last round date **May 2024**

Investors listed **2**

## On a portfolio page

Investors who name them

- [V-Bio Ventures](https://millionrounds.com/fund/v-bio-ventures)

Each firm lists BIODOL THERAPEUTICS on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care patent protection patents in pain therapy flt3 receptor extracellular receptor inhibitors allodynia reduction pain management animal models animal testing extracellular flt3 inhibitors medical research pain relief patented flt3 use innovative pain therapy flt3 receptor targeting neurological disorder

Built with from their website

OVHcloud Font Awesome Apache Viewport Meta Eventbrite Apache HTTP Server Mobile Friendly Modernizr jQuery Easy Pie Chart

+3 more

Mailinblack bxSlider Magnific Popup

- **Sector:** Pharmaceuticals
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** Occitanie
- **Revenue:** 1.5M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/biodol-therapeutics)

## Pharmaceuticals in France

Startups like it

- [**Unither Pharmaceuticals** Paris · founded 1993](https://millionrounds.com/startup/unither-pharmaceuticals)
- [**Biose Industrie** Aurillac · founded 1951](https://millionrounds.com/startup/biose-industrie)
- [**Veracyte Biopharma Services** Marseille · founded 2015](https://millionrounds.com/startup/veracyte-biopharma-services)
- [**Exeliom Biosciences** Dijon · founded 2016](https://millionrounds.com/startup/exeliom-biosciences)
- [**Pierre Fabre Laboratories** Toulouse · founded 1962](https://millionrounds.com/startup/pierre-fabre-laboratories)
- [**Futura Gaïa** Rodilhan · founded 2019](https://millionrounds.com/startup/futura-ga-a)
- [**Tamrisa** Paris · founded 2024](https://millionrounds.com/startup/tamrisa)
- [**BIOPHTA** Paris · founded 2020](https://millionrounds.com/startup/biophta)

## Is this your company?

Add your raise, your deck and your story, and put BIODOL THERAPEUTICS in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)